Single User License
INR 101130
Site License
INR 202260
Corporate User License
INR 303390

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Ferring International Center S.A.-Product Pipeline Review-2015

Ferring International Center S.A.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Ferring International Center S.A.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Ferring International Center S.A.-Product Pipeline Review-2015', provides an overview of the Ferring International Center S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ferring International Center S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Ferring International Center S.A. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Ferring International Center S.A.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Ferring International Center S.A.'s pipeline products

Reasons To Buy

Evaluate Ferring International Center S.A.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Ferring International Center S.A. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Ferring International Center S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Ferring International Center S.A. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ferring International Center S.A.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Ferring International Center S.A. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Ferring International Center S.A. Snapshot 6

Ferring International Center S.A. Overview 6

Key Information 6

Key Facts 6

Ferring International Center S.A.-Research and Development Overview 7

Key Therapeutic Areas 7

Ferring International Center S.A.-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Partnered Products 12

Partnered Products/Combination Treatment Modalities 13

Pipeline Products-Out-Licensed Products 14

Out-Licensed Products/Combination Treatment Modalities 15

Ferring International Center S.A.-Pipeline Products Glance 16

Ferring International Center S.A.-Late Stage Pipeline Products 16

Phase III Products/Combination Treatment Modalities 16

Ferring International Center S.A.-Clinical Stage Pipeline Products 17

Phase II Products/Combination Treatment Modalities 17

Phase I Products/Combination Treatment Modalities 18

Ferring International Center S.A.-Early Stage Pipeline Products 19

Preclinical Products/Combination Treatment Modalities 19

Ferring International Center S.A.-Drug Profiles 20

degarelix 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

elobixibat 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

follitropin delta 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Testavan 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

barusiban 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

FE-202767 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

FE-992097 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

FE-999301 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

FE-999309 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Ova-Treg 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

selepressin 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

FE-204205 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

FE-201874 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

FE-999310 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Ferring International Center S.A.-Pipeline Analysis 37

Ferring International Center S.A.-Pipeline Products by Target 37

Ferring International Center S.A.-Pipeline Products by Route of Administration 38

Ferring International Center S.A.-Pipeline Products by Molecule Type 39

Ferring International Center S.A.-Pipeline Products by Mechanism of Action 40

Ferring International Center S.A.-Recent Pipeline Updates 41

Ferring International Center S.A.-Dormant Projects 44

Ferring International Center S.A.-Locations And Subsidiaries 45

Head Office 45

Other Locations & Subsidiaries 45

Appendix 50

Methodology 50

Coverage 50

Secondary Research 50

Primary Research 50

Expert Panel Validation 50

Contact Us 50

Disclaimer 51

List of Tables

Ferring International Center S.A., Key Information 6

Ferring International Center S.A., Key Facts 6

Ferring International Center S.A.-Pipeline by Indication, 2015 9

Ferring International Center S.A.-Pipeline by Stage of Development, 2015 10

Ferring International Center S.A.-Monotherapy Products in Pipeline, 2015 11

Ferring International Center S.A.-Partnered Products in Pipeline, 2015 12

Ferring International Center S.A.-Partnered Products/ Combination Treatment Modalities, 2015 13

Ferring International Center S.A.-Out-Licensed Products in Pipeline, 2015 14

Ferring International Center S.A.-Out-Licensed Products/ Combination Treatment Modalities, 2015 15

Ferring International Center S.A.-Phase III, 2015 16

Ferring International Center S.A.-Phase II, 2015 17

Ferring International Center S.A.-Phase I, 2015 18

Ferring International Center S.A.-Preclinical, 2015 19

Ferring International Center S.A.-Pipeline by Target, 2015 37

Ferring International Center S.A.-Pipeline by Route of Administration, 2015 38

Ferring International Center S.A.-Pipeline by Molecule Type, 2015 39

Ferring International Center S.A.-Pipeline Products by Mechanism of Action, 2015 40

Ferring International Center S.A.-Recent Pipeline Updates, 2015 41

Ferring International Center S.A.-Dormant Developmental Projects,2015 44

Ferring International Center S.A., Other Locations 45

Ferring International Center S.A., Subsidiaries 46

List of Figures

Ferring International Center S.A.-Pipeline by Top 10 Indication, 2015 8

Ferring International Center S.A.-Pipeline by Stage of Development, 2015 10

Ferring International Center S.A.-Monotherapy Products in Pipeline, 2015 11

Ferring International Center S.A.-Partnered Products in Pipeline, 2015 12

Ferring International Center S.A.-Out-Licensed Products in Pipeline, 2015 14

Ferring International Center S.A.-Pipeline by Top 10 Target, 2015 37

Ferring International Center S.A.-Pipeline by Top 10 Route of Administration, 2015 38

Ferring International Center S.A.-Pipeline by Top 10 Molecule Type, 2015 39

Ferring International Center S.A.-Pipeline Products by Top 10 Mechanism of Action, 2015 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Ferring International Center S.A.; Ferring International Center S.A. - Key Therapeutics; Ferring International Center S.A. - Pipeline Overview and Promising Molecules; Ferring International Center S.A. - News; Ferring International Center S.A. - Latest Updates; Ferring International Center S.A. - Pipeline; Ferring International Center S.A. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com